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ABSTRACT: Antifreeze proteins (AFPs) can produce a difference between the nonequilibrium freezing point
and the melting point, termed thermal hysteresis (TH). The TH activity of an antifreeze protein (AFP)
depends on the specific AFP and its concentration as well as the presence of cosolutes including lowmolecular
mass solutes and/or proteins. We recently identified series of carboxylates and polyols as efficient enhancers
for an AFP from the beetle Dendroides canadensis. In this study, we chemically modified DAFP-1 using the
arginine-specific reagent 1,2-cyclohexanedione. We demonstrated that 1,2-cyclohexanedione specifically
modifies one arginine residue and the modified DAFP-1 loses its enhancing ability completely or partially in
the presence of previously identified enhancers. The stronger the enhancement ability of the enhancer on the
native DAFP-1, the stronger the enhancement effect of the enhancer on the modified DAFP-1. The weaker
enhancers (e.g., glycerol) completely lose their enhancement effect on the modified DAFP-1 due to their
inability to compete with 1,2-cyclohexanedione for the arginine residue. Regeneration of the arginine residue
using hydroxylamine fully restored the enhancing ability of DAFP-1. These studies indicated that an arginine
residue is critical for the enhancing ability of DAFP-1 and the guanidinium group of the arginine residue is
important for its interaction with the enhancers, where the general mechanism of arginine-ligand interaction
is borne. This work may initiate a complete mechanistic study of the enhancement effect in AFPs.
As an adaptive response to cold environmental conditions,
many organisms, such as fish and insects, have developed
antifreeze proteins (AFPs)1 that allow them to survive at
subfreezing temperatures.AFPs are characterized by their unique
abilities to lower the freezing point of water without affecting the
melting point. The gap between the nonequilibrium freezing and
melting points is termed thermal hysteresis (TH) and is usually
used as a measure of the activity of AFPs (1). The adsorp-
tion-inhibition mechanism of AFP function states that AFPs
depress the freezing point by absorbing onto the ice crystal
surface at preferred growth sites (2-5). The interactions between
the AFP and the ice can be one of, or any combination of,
hydrophobic interactions, van der Waals interactions (6, 7), and
hydrogen bonds (8, 9).
Beetle AFPs typically exhibit high antifreeze activities com-
pared to fish AFPs. Beetle AFPs from Dendroides canadensis
(DAFPs) are a family of 13 known AFPs containing varying
numbers of 12- or 13-mer repeats with sizes of 7.3-16.2 kDa (10).
There are 16 Cys residues well distributed in the seven repeats in
the isomer, DAFP-1, all of which are disulfide bridged
(Figure 1A). The resulting eight disulfide bonds make DAFP-1
highly stable (11). In addition, there are four Arg and two Lys
residues in DAFP-1.
The activities of many AFPs can be further enhanced in the
presence of certain cosolutes. Both small molecules and macro-
molecules have been identified as enhancers for DAFP-
1 (12-19). Recently, various series of efficient low molecular
mass enhancers have been reported; however, the mechanism of
enhancement still remains elusive (14, 15, 20, 21).
In searching for highly efficient lowmolecular mass enhancers,
the understanding of the molecular mechanisms of the AFP
enhancers and the enhancing function of AFPs are both critically
important. In order to understand the molecular mechanism of
AFP enhancers, we first correlated the enhancement abilities of
the enhancers with their varying physicochemical properties and
reported series of polycarboxylates and polyols as efficient AFP
enhancers (14, 15). As more highly efficient enhancers have been
identified, we have noticed that almost all of the low molecular
mass enhancers can interact with the guanidinium group of
arginine and/or the ammonium group of lysine through one or
any combination of the following interactions: ionic interaction,
hydrogen bonding, and hydrophobic interaction.
In this study, we examine the role of arginine in the enhan-
cing function of DAFP-1. Here, we report the modification of
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arginine in DAFP-1 and the effect of the modification on the
enhancing function of DAFP-1 in the presence of various low
molecular mass enhancers. This work demonstrates that arginine
inDAFP-1 plays a critical role in the enhancing ability ofDAFP-1
and provides important information regarding the binding
between AFPs and enhancer molecules.
MATERIALS AND METHODS
DAFP-1 3D Structure. The starting 3D structure of DAFP-
1was created from a homologymodel of aTenebriomolitorAFP,
TmAFP (PDB code 1EZG) that has considerable sequence
homology to DAFP-1, using the 3D-JIGSAW (22-24) online
structure prediction tool. This structure was immersed in a 69 A˚,
preequilibrated, cubic box of water molecules described by the
F3C (25) water model. The water molecules that overlapped the
protein were removed, and 1 Naþ counterion was added to
achieve charge neutrality. The system was then simulated
for 1.5 ns of NPT dynamics at 1 bar and 300 K, after
initial energyminimization and heating, using the LAMMPS (26)
MD code, with the protein described by the AMBER99 (27)
force field. Snapshots of the system were saved every
10 ps, with the final snapshot taken as the equilibrated 3D
structure (28).
Materials. 1,2-Cyclohexanedione, hydroxylamine hydro-
chloride, and all of the tested enhancer compounds were pur-
chased from Sigma-Aldrich (St. Louis, MO) at ACS grade or
better. All of the chemicals were used without additional
purification. Solvents and chemicals for the HPLC experiments
were purchased at HPLC grade from Sigma-Aldrich (St. Louis,
MO). All of the aqueous solutions were prepared using Milli-Q
water produced from a Synergy water system (Millipore Co.)
with a minimum resistivity of 18 MΩ 3 cm. The protein samples
were in 50 mM sodium borate buffer, pH 9.0, and all of the
samples were filtered through a 0.2 μm filter before use unless
otherwise indicated.
Protein Expression and Purification. DAFP-1 was ex-
pressed and purified as described previously (14). In brief,
DAFP-1 was expressed as a fusion protein with thioredoxin,
His, and S tags in Escherichia coliOrigami B cells. The cells were
harvested by centrifugation at 4 C and then were disrupted by
passing through a French press (Thermo Fisher) at 1250 psi two
to three times. The crude protein was purified using Ni-NTA
agarose (Qiagen). The tags were cleaved using enterokinase (New
England Biolabs) and removed using Ni-NTA agarose. The
cleaved protein was finally purified using €AKTA Purifier 10
(GE Healthcare) with a Sephacryl S-100 gel filtration column
(GE Healthcare). The identity of the purified protein was
confirmed by SDS-PAGE, HPLC, and matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF) mass spec-
trometry. The protein concentration was determined by UV-vis
spectroscopy (Cary 100 Bio; Varian) using the absorption at
280 nm (ε280=5.47  103 M-1 cm-1) (29).
Reaction of DAFP-1 with Arginine-Modifying Agents
and Reversal of the Reaction with Hydroxylamine. In a
typical reaction, a 10-fold molar excess of freshly made 1,2-
cyclohexanedione to arginine was incubated with DAFP-1 in
0.10 M borate buffer, pH 9.0, in the dark for as long as 3 h at
37 C. The sample pH was 9.0 and was adjusted using 0.20 M
NaOH if necessary. DAFP-1 treated under the same conditions
without 1,2-cyclohexanedione was used as a control. Aliquots
were taken every 1 h for TH activity measurement and for mass
spectrometry to determine the extent of modification. The excess
1,2-cyclohexanedione was removed by a PD-10 desalting column
(GEHealthcare) equilibrated with 0.10 M sodium borate buffer,
pH 9.0. In the modified DAFP-1, the conjugated π system of 1,2-
cyclohexanedione is destroyed. The UV absorption properties at
280 nm are mainly derived from the Tyr residues and to a small
extent on the amount of disulfide bonds. The extinction coeffi-
cient of the modified DAFP-1 is the same as that of the native
DAFP-1 (ε280=5.47 103 M-1 cm-1). The concentration of the
modified DAFP-1 was determined using a Cary 100 Bio UV-vis
spectrophotometer. In order to test whether hydroxylamine
would reverse this modification, the modified DAFP-1 was
incubated with 0.60 M hydroxylamine, pH 7.0, for 6 h in the
dark at 37 C under N2. After the excess hydroxylamine and
other small molecules were removed, the arginine-regenerated
FIGURE 1: Structures of DAFP-1 from D. canadensis. (A) The
sequence of DAFP-1 with the location of the disulfide bridges (11).
(B) Model of DAFP-1 tertiary structure. The eight disulfide bridges
are shown in yellow. The positions of the four arginine residues are
labeled. DAFP-1 consists of seven repeats, and Arg9 is located in the
first irregular repeat.
FIGURE 2: Reaction scheme of the key arginine in DAFP-1 with 1,2-
cyclohexanedione at pH 9.0 in 0.10 M sodium borate buffer.
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DAFP-1was concentrated, and its concentrationwas determined
as above.
MALDIMass Spectrometry.Matrix-assisted laser desorp-
tion ionization time-of-flight (MALDI-TOF) mass spectra were
obtained on a PerSeptive Biosystems/Voyager-DE MALDI-
TOF mass spectrometer at the Stanford PAN facility. Calibra-
tions of the mass spectrometer against external mass standards
were carried out before the sample analysis. Matrix, sinapinic
acid, was prepared as a saturated solution in 1:1 (v/v) water:
acetonitrile with 0.1% trifluoroacetic acid (TFA). After being
desalted using Ziptip C18 resin (Millipore), the sample was
dissolved in doubly distilled H2O-TFA at pH 3.0. Then
0.5 μL of the sample solution was mixed with an equal volume
of the saturated matrix solution in a MALDI sample plate and
air-dried before analysis.
Quantitative Analysis of the Modification Reaction of
DAFP-1. HPLC chromatograms were recorded on a computer
connected to the HPLC system (Dionex, Sunnyvale, CA) con-
sisting of an Ultimate 3000 pump and an Ultimate 3000 photo-
diode array detector. The samples were injected on a BioSuite
125, 4 μm UHR SEC HPLC column, 4.6  300 mm (Waters,
Milford, MA). The aqueous buffer for SEC consisted of 0.10 M
sodium borate and 0.10 M Na2SO4, pH 8.50. All of the buffers
and samples were filtered through a 0.1 μm filter and were
vacuum degassed before use. The flow rate was 0.50 mL/min at
ambient temperature. The reaction mixtures were prepared by
incubating equal volumes of 1.160 mM 1,2-cyclohexanedione
and 0.290 mMDAFP-1 and of 1.910 mM 1,2-cyclohexanedione
and 0.139 mM DAFP-1 as described above for 1 h. Then the
elution profiles of the reaction mixtures, the DAFP-1 control,
and 1,2-cyclohexanedionewere procured. The consumed amount
of 1,2-cyclohexanedione obtained from the HPLC elution pro-
files was used to estimate the stoichiometry of the reaction.
Thermal Hysteresis Activity Measurements. The deter-
minations of the thermal hysteresis (TH) activities followed the
known procedure using differential scanning calorimetry (DSC)
except that 0.05M sodium borate buffer, pH 9.0, was used in this
study (15). The measurements were performed on a DSC 823e
(Mettler, Toledo,OH)with anHSS7 high-sensitivity sensor and a
Julabo FT900 intracooler chiller (Julabo Co., Allentown, PA).
The protein concentrations were 320 μM in all of the samples.
The enhancing abilities of glycerol, trehalose, and sodium citrate
were assessed on DAFP-1 (the control), the Arg-modified
DAFP-1, and the arginine-regenerated DAFP-1. In addition,
the following previously identified enhancers, ethanol, ethylene
glycol, threitol, glucose, sodium acetate, sodium glutarate
(GTA), sodium tricarboxylate (TCA), sodium ethylenediamine-
tetraacetate (EDTA), sodium diethylenetriaminepentaacetate
(DTPA), and sodium triethylenetetramine-N,N,N0,N00,N0 0 0,N0 00-
hexaacetate (TTHA), were tested for the ability to enhance the
TH of both DAFP-1 (the control) and the Arg-modified DAFP-
1. The tested concentrations of the enhancers were varied from
0.00 to 1.5 M (depends on the solubility). Each combination of
DAFP-1 and enhancer was made up three times, and the TH of a
given sample was measured at least twice. The TH values were
presented as means, and the standard deviations were 0.02 C.
Circular Dichroism (CD) Spectroscopy. CD spectra were
measured on a Jasco 810 spectropolarimeter at ambient tem-
perature using a quartz cuvette with a path length of 0.1 cm.
Protein samples were prepared at a concentration of 15 μM in
50 mM sodium borate buffer, pH 9.0. The buffer contributions
were subtracted from the sample spectra. The far-UV CD
spectrum (190-260 nm) of each sample was reported as an
average of three scans in molar ellipticity.
RESULTS
DAFP-1 3D Structure. There is no higher order structure
available for DAFP-1 to view the arginines. A model of DAFP
was proposed, but it did not indicate which DAFP isoform was
modeled or shows the arginine residues (3). Therefore, a model of
the tertiary structure of DAFP-1 (Figure 1B) was built here and
was subsequently used to locate arginine side chains with respect
to the remainder of DAFP-1 structure. The model structure of
DAFP-1 shows that the side chains of all of the arginine residues
FIGURE 3: MALDI-TOFmass spectrum of arginine-modified DAFP-1 products. A and C represent products A and C in Figure 2, respectively.
M represents the molecular fragment of the products. The asterisk (*) indicates the borate complexes of product C.
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to some extent point away from the protein surface (Figure 1B).
Arg9 is located in the only irregular repeat, repeat 1. The side
chain of Arg25 reaches too far away from the surface to form any
contacts with other residues in DAFP-1, and those of Arg30 and
Arg54 have similar conformations to each other.
Arginine-Modified DAFP-1 by Reaction with 1,2-Cy-
clohexanedione. The arginine modification of DAFP-1 was
performed by the reaction of 1,2-cyclohexanedione and DAFP-1
at pH 9.0 in 0.10M sodiumborate as sketched inFigure 2. To test
the kinetics of themodification reaction, aliquots taken after 1, 2,
and 3 h of incubationwere analyzed byHPLCandMALDI-TOF
mass spectrometry. Nearly identical results were obtained from
all three aliquots, which suggests the reaction can be completed in
1 h. Thus, all of the modified DAFP-1 samples used for
enhancing ability tests were then prepared by 1 h incubation
with 1,2-cyclohexanedione. Figure 3 shows the MALDI-TOF
mass spectrum of DAFP-1 incubated with 1,2-cyclohexanedione
for 1 h. It is known that 1,2-cyclohexanedione attacks only
arginine residues in a protein under the mild conditions we
used (30, 31). As revealed in Figure 3, there is no lysine
modification in DAFP-1, and only one of the four arginines in
DAFP-1 was modified although a large excess of 1,2-cyclohex-
anedione was used in the reaction. The calculatedmolecularmass
of DAFP-1 is 8968.8 Da. The two peaks at 9064.0 and 9097.2 are
due to one arginine-modified DAFP-1, associated with the 1:1
products A and C, respectively, while the peak at 8968.8 is
associated with the DAFP-1 fragment dissociated from the
modified DAFP-1 (Figures 2 and 3).
Furthermore, the stoichiometry of the reaction between 1,2-
cyclohexanedione and DAFP-1 was estimated to be 1:1 by
FIGURE 4: UVabsorption detected size exclusionHPLCprofiles of (A) 1,2-cyclohexanedione (1.160mM, 8 μL, retention time tR=11.5min) and
(B) the reactionmixture ofDAFP-1 (0.290mM, 8 μL, tR=7.1min) and 1,2-cyclohexanedione (1.160mM, 8 μL, tR=11.5min). Themolar ratio of
DAFP-1 to 1,2-cyclohexanedione in the reactionmixture was 1:4. The ratio of the area under peak a (Aa=38.9mAu 3min) to the area under peak
a0 (Aa0=29.0 mAu 3min) is 4:3, indicating only one-fourth of the original amount of 1,2-cyclohexanedione was consumed.
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analyzing the decrease of the UV absorption of 1,2-cyclohex-
anedione in the size exclusion HPLC profiles obtained with
varied reactant molar ratios. A typical example is presented in
Figure 4. The elution peak of 1,2-cyclohexanedione was de-
creased by exactly one-fourth in the reaction mixture of DAFP-1
and 1,2-cyclohexanedione with a molar ratio of 1:4 (Figure 4B).
Another special example is shown in the Supporting Information,
in which 9.55 pmol of 1,2-cyclohexanedione (Supporting Infor-
mation Figure S1A,B) and 0.695 pmol of DAFP-1 (Supporting
InformationFigure S1B)were used. Similar results were obtained
though this nonintegral molar ratio of DAFP-1 and 1,2-cyclo-
hexanedione with the amount of 1,2-cyclohexanedione is more
than 10 times in excess of that of DAFP-1 used in the reaction
(Supporting Information Figure S1). These results suggest that
one arginine residue in DAFP-1 is modified under these condi-
tions.
Thermal Hysteresis Characterization. In the control, in
which DAFP-1 was treated the same as the treated DAFP-1
except that 1,2-cyclohexanedione was not added, the TH activ-
ities in the absence and in the presence of low molecular mass
enhancers were in agreement with those previously reported for
DAFP-1 (14, 15). The TH activity of Arg-modified DAFP-1
alone was the same as those of the control or the native DAFP-1,
while the efficiencies of the antifreeze enhancement in the Arg-
modified DAFP-1 in the presence of different enhancers were
decreased to different extents or completely abolished
(Figures 5-7 and Supporting Information Figures S2-S4).
The ability of the modified DAFP-1 to be enhanced was
completely lost in the presence of weak enhancers. The results
further support that the modification reaction was complete
within 1 h, and there was little unmodified DAFP-1 in the
solution. To test the completion of the reaction of the modified
DAFP-1 with enhancers, the modified DAFP-1 and three
representative enhancers (glycerol as a weak enhancer, trehalose
as a medium to strong enhancer, and citrate as a stronger
enhancer) were incubated at room temperature for different time
periods (0.5, 1, and 2 h, respectively) before thermal hysteresis
activity measurements. Little changes in the TH activities of the
samples with different incubation time were observed, indicating
the equilibrium was reached within 30 min at ambient tempera-
ture (data not shown). Thus the incubation time of 0.5 hwas used
for the modified DAFP-1 with the enhancers for all of the
measurements in this study.
The TH activities of the modified DAFP-1 in the presence of
the weak enhancers (e.g., glycerol) were nearly identical to that
of the native DAFP-1 alone (Figure 5 and Supporting In-
formation Figures S2 and S3). The ability of DAFP-1 to be
enhanced by these weak enhancers was completely abolished
after the arginine residue was modified in DAFP-1. In con-
trast, in the presence of relatively stronger enhancers, such as
trehalose, citrate, and EDTA, the ability to be enhanced can be
partially regained in the modified DAFP-1, indicating that
ability of the modified DAFP-1 to be enhanced appears to be
positively associated with the enhancement abilities of these
enhancers (Figures 6 and 7 and Supporting Information
Figures S2-S4). This suggests that these stronger enhancers
can compete with the 1,2-cyclohexanedione for the side chain
of the arginine residue in DAFP-1 (a proposed scheme is
shown in Figure 8) and that they form complexes with DAFP-
1. The peak of the complex of DAFP-1 and citrate (as a
stronger enhancer) was indeed observed in the MALDI-TOF
FIGURE 5: Antifreeze activities of DAFP-1 (b), the Arg-modified
DAFP-1 (2), and the Arg-modified DAFP-1 after treatment with
NH2OH () in the presence of varying concentrations of glycerol in
50 mM borate buffer, pH 9.0.
FIGURE 6: Antifreeze activities of DAFP-1 (b), the Arg-modified
DAFP-1 (2), and the Arg-modified DAFP-1 treated with NH2OH
() in the presence of varying concentrations of trehalose in 50 mM
borate buffer, pH 9.0.
FIGURE 7: Antifreeze activities of DAFP-1 (b), the Arg-modified
DAFP-1 (2), and the Arg-modified DAFP-1 treated with NH2OH
() in the presence of varying concentrations of sodium citrate in
50 mM borate buffer, pH 9.0.
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mass spectrum (Supporting Information Figure S5), suggest-
ing the formation of a complex of DAFP-1 and a stronger
enhancer. The arginine modification reaction by 1,2-cyclohex-
anedione is usually reversible, and the arginine can be regen-
erated if treated by hydroxylamine (30). As expected, the
enhancing ability of the protein samples was nearly fully
recovered in the presence of the previously tested enhancers
after the modified DAFP-1 was treated in 0.5 M hydroxyla-
mine, pH 7.0, for 6 h (Figures 5-7). These results suggest
that the arginine residue does not account for the antifreeze
activity of DAFP-1 but is critical for the enhancing ability of
DAFP-1.
CD Spectra of DAFP-1 and Modified DAFP-1. CD
spectra (Figure 9) were obtained for both DAFP-1 and the
Arg-modified DAFP-1 to determine whether the secondary
structure of the native protein was retained in the modified
DAFP-1. As earlier reported with the protein isolated from
D. canadensis hemolymph (32), the far-UV CD spectrum of
DAFP-1 showed negative ellipticity near 195 nm and two
minima around 203 and 222 nm, respectively, with a much
broader 222 nm band (Figure 9). These characteristics were also
seen in the CD spectra of the expressed DAFP-1 used in this
study, indicating that it also consists primarily of turns and short
β-sheet structures (32). Furthermore, there were no apparent
differences in the CD spectra of DAFP-1 and Arg-modified
DAFP-1 (Figure 9), indicating that the modification of DAFP-1
does not introduce major changes in the protein structure.
DISCUSSION
Both small molecules and proteins have been reported to be
able to enhance the TH activity of AFPs (12-18, 20). It has been
demonstrated that the TH activity enhancement effects of
the protein enhancers are due to their ability to bind to
DAFPs (21, 33). Despite persistent studies, the enhancer binding
sites of small molecular mass enhancers in AFPs are essentially
unknown (14, 15, 20, 21). In this study, by using a chemically
modified DAFP-1, we demonstrated that an arginine residue in
DAFP-1 is critical for the TH enhancing ability of DAFP-1 by
small enhancers. The mass spectrum shows the product peaks
with one arginine modification, indicating that the modification
is only for arginine and only one of the four arginine residues in
DAFP-1 was modified (Figure 3). The modification of arginine
by 1,2-cyclohexanedione is well-known to be reversed by hydro-
xylamine (30), and because the enhancing ability of the modified
DAFP-1 was fully restored by hydroxylamine treatment
(Figures 6-8), this also indicates that the modification only
affects an arginine residue. The analytical HPLC results provide
further support that the stoichiometry of the reaction between
1,2-cyclohexanedione and DAFP-1 is 1:1 (Figure 4). DAFP-1
consists of seven tandem 12- or 13-residue repeats. All of the
16 Cys residues in DAFP-1 are disulfide bridged and form seven
intrarepeat disulfide bonds and one interrepeat disulfide bond.
The interrepeat disulfide bond links repeat 1 and repeat 2. The
four arginines, Arg9, Arg25, Arg30, and Arg54, are located in
repeat 1, 2, 3, and 5, respectively. Arginine-ligand interactions
are known to exist in aqueous phase only when there are
hydrophobic interactions and/or hydrogen bonds with other
amino acids (37). The simple ion pairs between guanidinium
cations and ligands are not stable in aqueous solutions, since
water can compete for both donor and acceptor sites for the
ligand solvation and decrease the stability of the ion pairs
significantly. The side chain of Arg25 reaches too far away from
the surface to form any contacts with other residues in DAFP-1,
which makes it less possible for the Arg-enhancer pair to be
stabilized. Thus Arg25 has the least possibility to be the key Arg
for the enhancing ability of DAFP-1. The side chains of Arg30
and Arg54 have similar conformations (Figure 1). Due to the
repeat structure of DAFP-1, Arg30 and Arg54 are located in a
similar environment. Since only one Arg residue was involved in
the enhancement molecular mechanism, the similarities between
Arg30 andArg54make them less possible to be the keyArg.Arg9
is located in the irregular repeat, repeat 1, next to the only
interrepeat disulfide bond at the N-terminus (Figure 1) and may
have the highest possibility of being the critical arginine residue
for the enhancing ability of DAFP-1. The model structure of
FIGURE 8: Proposed binding of arginine in DAFP-1 with citrate.
FIGURE 9: CD spectra of DAFP-1 and the Arg-modifiedDAFP-1 in
50 mM borate buffer, pH 9.0. The protein concentrations were
15 μM. The experiments were performed at ambient temperature.
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DAFP-1 gives us some hints onwhich arginine plays amajor role
in the enhancing ability of DAFP-1. Studies are underway to
identify the key arginine and the assisting residues.
Guanidine is one of the most basic forms of neutral nitrogen
compounds,with a pKa of 13.5 inwater at room temperature (34).
This results from the stability of the conjugate acid (guanidinium)
in water, where the positive charge on guanidinium can be
distributed evenly among the three nitrogen atoms by reso-
nance (35, 36). When the guanidinium moiety of the arginine
residue was chemically modified with 1,2-cyclohexanedione, the
modified arginine residue lost the resonance stability in guanidi-
nium, and its ability to bind to anions was greatly reduced.
Furthermore, in contrast to a free arginine residue, the resulting
adducts have a five or six atom ring. The increased steric
hindrance of the modified arginine greatly reduces the possibility
of the formation of interactions such as hydrogen bonds and/or
ionic interactions among guanidinium and the ligand (or en-
hancer). As a result themodified arginine residue lost its ability to
bind to the enhancer molecules, completely in the case of weak
enhancers or partially with strong enhancers.
The 1,2-cyclohexanedione modification of arginine is a rever-
sible reaction in borate buffer at pH 9.0 (30). In the presence of
enhancermolecules that can bind to the side chain of arginine, the
competition for arginine between the enhancer molecules and
1,2-cyclohexanedione will occur until a chemical equilibrium is
finally reached (Figures 2 and 8). In this study, the competition
for the guanidinium group in the arginine residue in DAFP-1
between a strong enhancer and 1,2-cyclohexanedione was sug-
gested by the partial retrieval of the enhancing ability of the
modifiedDAFP-1 in the presence of a strong enhancer (Figure 8).
The stronger the enhancer presented, the more efficient the
competition of the enhancer with the arginine residue in
DAFP-1 and the greater the enhancement effect on the modified
DAFP-1 (Figures 5-7). The weaker enhancers (e.g., glycerol),
however, were not able to compete for the arginine residue,
resulting in the complete loss of their enhancement abilities. In
the case of citrate, the simple ion pairs between the guanidinium
cation and citrate are not very stable in aqueous solution as water
molecules compete for the formation of the ion pairs by solvating
the individual ions. The solvates of the guanidinium cation and
citrate greatly decrease the stability of their ion pairs, leading to
the breakup of the ion pairs. Other amino acids in DAFP-1 may
assist the formation of the ion pairs between the guanidinium
cation and citrate by interacting with citrate through hydrogen
bonds, van der Waals contacts, and/or hydrophobic interactions
to stabilize the products. The product peak of the 1:1 complex of
DAFP-1 and citric acid was observed in the MALDI-TOF mass
spectrum (Supporting Information Figure S5).
The identification of the participation of arginine in the
recognition of enhancers in DAFP-1 may initiate a more
complete mechanistic study of the enhancement effect in
AFPs. Simple anions (e.g., Cl- and Br-) that have only ionic
interaction with the guanidinium cation are usually very weak
enhancers. Likewise, simple organic molecules (e.g., ethanol)
having weak hydrogen-bonding and hydrophobic interactions
with the arginine and DAFP-1 are also weak enhancers, while
carbohydrates having multiple hydrogen bonds and hydro-
phobic interactions with the arginine and DAFP-1 are better
enhancers. Only those molecules that can interact with the key
factors in DAFP-1 more extensively by all the possible ways
(namely, ionic binding, hydrogen bonding, and hydrophobic
interaction) function as efficient enhancers (e.g., EDTA and
citrate) (15). This requirement is consistent with known
arginine-ligand interactions (37-39).
The guanidinium cation is a good molecular recognition
motif for oxoanion binding in nature (37, 40). The great
basicity of the guanidine functional group allows it to play
key roles in recognition and catalysis (41, 42), while the
guanidinium group of Arg is widely used as a mediator for
noncovalent binding in the biological world, such as oxoa-
nionic enzyme substrates and the base pairing in nucleic
acids (40). In addition, guanidinium can form hydrogen
bonds to polyhydroxy compounds (43), and the guanidi-
nium-oxoanion ionic pair can assist drug transport across
the cell membrane (44, 45). The results presented here bear on
the general mechanism of arginine-ligand interactions,
though the biological function of this interaction is novel:
the enhancing function of small molecular mass solutes on
DAFP-1 activity.We believe that (1) any good anion that pairs
to the guanidinium cation in nature and has strong hydrogen
bonding and hydrophobic interactions with AFPs is an
excellent candidate to be a DAFP-1 enhancer, (2) a similar
molecular mechanism is involved in the enhancement of the
other isomers of DAFP having arginines, and (3) other
potential key amino acid interaction pairs exist in other AFPs
that lack arginine residues, such as certain of theD. canadensis
DAFP isoforms and AFPs from T. molitor. Furthermore,
uncovering the details of the binding is the key step to the
design of superefficient enhancers for DAFP-1, by which we
may finally make DAFP-1 and its enhancers more useful in
applications. It is also important to address whether and how
other residues recognize and orient water and/or ice interac-
tions that help DAFP-1 bind tightly to the surface of the ice
crystal and finally increase the TH activity.
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